Avirmax Biopharma, Inc
$631.49 5 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Mf Med
Mf Med reported $630.54 across General Payments, Research, and Ownership to 18 physicians and teaching hospitals across 18 transactions.
- $630.54 Below-median payer
- All-tracks total
- 18 Below-median volume
- Transactions
- 18 Below-median reach
- Recipients
- #1867
- of 1,925 companies
Mf Med reported $630.54 across all CMS Open Payments tracks (General + Research + Ownership) to 18 physicians and teaching hospitals in Program Year 2024 - ranking #1867 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $630.54, averaging $35.03 per recipient.
Mf Med's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer mf-med Mf Med
$630.54 · #1867/1,925 · 0.0% industry · PY2024
- TOT $630.54
- RANK #1867
- SHARE 0.0%
- TXN 18
- RCP 18
- CAT 1
- GEN $630.54
- TOP1 20.9%
- PY 2024
Volume peers
Nearest volume peer: Avirmax Biopharma, Inc ($631.49)
Mf Med sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Mf Med
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Mf Med that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
"Food and Beverage" leads the 1-category general-payment breakdown below at $630.54 (100.0% of General Payments, 18 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Mf Med made 1 types of general payments. "Food and Beverage" is the largest category at $630.54, 100.0% of General Payments.
How Mf Med divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $630.54 | 18 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $387.45 (61.4%) of $630.54 in this company's General Payments records across 18 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Mf Med
The five named recipients with the highest reported General Payments from this company
- 1
Charles Cossell
$131.65 across 1 reported transactions
- 2
Brandon Horn
$83.95 across 1 reported transactions
- 3
Stephen Shively
$64.95 across 1 reported transactions
- 4
Eric Tannenbaum
$55.00 across 1 reported transactions
- 5
Ganeshan Ramachandran
$51.90 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Mf Med ranks #1867 of 1,925 by total payments (bottom 3% by spend) but is notably more concentrated than that alone would suggest -- #1,040 of 1,838 by HHI (bottom 43% least concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Tactile Systems Technology Inc : $810.5K total payments, HHI 989
- Vivus LLC : $184.4K total payments, HHI 986
- Geron Corporation : $91.2K total payments, HHI 985
- Macrogenics, Inc. : $1.1K total payments, HHI 985
- Rti Surgical, Inc : $1.4M total payments, HHI 982
- OssDsign Incorporated : $88.5K total payments, HHI 981
- Mf Med (this company) : $630.54 total payments, HHI 979
- B. Braun Medical Inc. : $221.2K total payments, HHI 975
- Vioptix Inc : $4.7K total payments, HHI 971
- Bolton Medical Inc : $2.2M total payments, HHI 970
- Ge Healthcare : $6.4M total payments, HHI 966
- Occlutech US LLC : $1.2M total payments, HHI 961
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Mf Med's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Mf Med.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Mf Med.
Showing 6 of 1,924 companies with CMS-reported payment data.
aap Implants Inc
$631.69 5 recipients
Compare payment profiles
Nurami Medical Ltd
$627.48 4 recipients
Compare payment profiles
curasan, Inc.
$621.57 9 recipients
Compare payment profiles
Cook Biotech Incorporated
$609.12 1 recipients
Compare payment profiles
Pixee Medical Inc.
$601.00 2 recipients
Compare payment profiles
Put this to use
Mf Med ranks #1867 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Mf Med. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.